Author details

Anastasia Nesterova\* and Anton Yuryev

\*Address all correspondence to: a.nesterova@elsevier.com

Elsevier Life Sciences Solutions, Rockville, Maryland, USA

#### References


[6] Brinkmann AO. Molecular mechanisms of androgen action—a historical perspective. Methods Mol Biol Clifton NJ. 2011;776:3–24. doi:10.1007/978-1-61779-243-4\_1

and relations pulled out from ResNet® database. ResNet® database storages dictionary and ontology of biological-related entities (proteins, small molecules, diseases, cell processes, cells, treatments, etc.) linked together by relations (such as protein 1-protein 2 "binding") (Figure 7). Relations depict facts supporting by sentences (references) with scientific evidences which are extracted from more than 3 million articles and manually curated when adding to pathways. The relations indicate the effect of relation (negative or positive), the direction of the relation, mechanism of the relation (such as phosphorylation), etc. [71]. The method of the pathway reconstruction required looking for common relationships to entities in the database (common downstream cell process or disease, upstream regulators, downstream expression targets, etc.)

Supplemental Table 1 and Supplemental Table 2 could be downloaded via link:

[1] Oh JW, Kloepper J, Langan EA, Kim Y, Yeo J, Kim MJ, et al. A guide to studying human hair follicle cycling in vivo. J Invest Dermatol. 2016;136:34–44. doi:10.1038/JID.2015.354

[2] Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci.

[3] Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97:247–54. doi:10.1111/j.1365-2133.

[4] Randall VA, Jenner TJ, Hibberts NA, De Oliveira IO, Vafaee T. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. J Endocrinol. 2008;197:11–

[5] Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J

Invest Dermatol. 1997;109:296–300. doi:10.1111/1523-1747.ep12335779

and reviewing manually the results.

https://data.mendeley.com/datasets/yfnrkc7r9x/1

\*Address all correspondence to: a.nesterova@elsevier.com

Elsevier Life Sciences Solutions, Rockville, Maryland, USA

Anastasia Nesterova\* and Anton Yuryev

Supplemental Information:

Author details

164 Hair and Scalp Disorders

References

1951;53:708–28

1977.tb15179.x

23. doi:10.1677/JOE-07-0522


[34] Midorikawa T, Chikazawa T, Yoshino T, Takada K, Arase S. Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis. J Dermatol Sci. 2004;36:25–32. doi:10.1016/j.jdermsci.2004.05.001

[22] Jaworsky C, Kligman A m., Murphy G f. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol. 1992;127:239–46.

[23] Lattanand A, Johnson WC. Male pattern alopecia a histopathologic and histochemical

[24] Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia.

[25] Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss

[26] Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB. Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet. 2007;121:451–7. doi:10.1007/s00439-006-

[27] Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. II. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;39:1012–9.

[28] Chen W, Tsai S-J, Liao C-Y, Tsai R-Y, Chen Y-J, Pan B-J, et al. Higher levels of steroidogenic acute regulatory protein and type I 3beta-hydroxysteroid dehydrogenase in the scalp of men with androgenetic alopecia. J Invest Dermatol. 2006;126:2332–2335.

[29] Inui S, Itami S. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011;61:1–6. doi:10.1016/j.jdermsci.2010.

[30] Rutberg SE, Kolpak ML, Gourley JA, Tan G, Henry JP, Shander D. Differences in expression of specific biomarkers distinguish human beard from scalp dermal papilla cells. J

[31] Chew EGY, Tan JHJ, Bahta AW, Ho BS-Y, Liu X, Lim TC, et al. Differential expression between human dermal papilla cells from balding and non-balding scalps reveals new candidate genes for androgenetic alopecia. J Invest Dermatol. 2016;136:1559–67.

[32] Goodarzi HR, Abbasi A, Saffari M, Fazelzadeh Haghighi M, Tabei MB, Noori Daloii MR. Differential expression analysis of balding and nonbalding dermal papilla microRNAs in male pattern baldness with a microRNA amplification profiling method.

[33] Kim SJ, Dix DJ, Thompson KE, Murrell RN, Schmid JE, Gallagher JE, et al. Gene expression in head hair follicles plucked from men and women. Ann Clin Lab Sci.

Invest Dermatol. 2006;126:2583–2595. doi:10.1038/sj.jid.5700454

Br J Dermatol. 2012;166:1010–6. doi:10.1111/j.1365-2133.2011.10675.x

study. J Cutan Pathol. 1975;2:58–70. doi:10.1111/j.1600-0560.1975.tb00209.x

doi:10.1111/j.1365-2133.1992.tb00121.x

Study Group. J Am Acad Dermatol. 1998;39:578–89.

Dermatol Clin. 1996;14:697–711

doi:10.1210/jcem-39-6-1012

doi:10.1038/sj.jid.5700442

doi:10.1016/j.jid.2016.03.032

2006;36:115–26.

0317-8

166 Hair and Scalp Disorders

10.015


[59] Rahmani W, Abbasi S, Hagner A, Raharjo E, Kumar R, Hotta A, et al. Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type. Dev Cell. 2014;31:543–58. doi:10.1016/j.devcel.2014.10.022

[47] Kitagawa T, Matsuda K-I, Inui S, Takenaka H, Katoh N, Itami S, et al. Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal

papilla cells. J Clin Endocrinol Metab. 2009;94:1288–1294. doi:10.1210/jc.2008-1053

keratinocytes. J Invest Dermatol. 2008;128:262–9. doi:10.1038/sj.jid.5700999

hair follicle development. Dev Cell. 2002;2:643–53.

doi:10.1038/jid.2011.274

71. doi:10.1111/j.0303-6987.2005.00397.x

2012. doi:10.1007/s00018-012-1000-y

2008;128:1088–94. doi:10.1038/sj.jid.5701147

doi:10.1111/j.1432-0436.2004.07209008.x

1242/jcs.02786

168 Hair and Scalp Disorders

[48] Kwack MH, Sung YK, Chung EJ, Im SU, Ahn JS, Kim MK, et al. Dihydrotestosteroneinducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular

[49] Andl T, Reddy ST, Gaddapara T, Millar SE. WNT signals are required for the initiation of

[50] Inui S, Fukuzato Y, Nakajima T, Kurata S, Itami S. Androgen receptor co-activator Hic-5/ ARA55 as a molecular regulator of androgen sensitivity in dermal papilla cells of human hair follicles. J Invest Dermatol. 2007;127:2302–6. doi:10.1038/sj.jid.5700883

[51] Kwack MH, Ahn JS, Kim MK, Kim JC, Sung YK. Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice. J Invest Dermatol. 2012;132:43–49.

[52] Gilliver SC, Ashworth JJ, Mills SJ, Hardman MJ, Ashcroft GS. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119:722–32. doi:10.

[53] Lee P, Zhu C-C, Sadick NS, Diwan AH, Zhang PS, Liu JS, et al. Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia. J Cutan Pathol. 2005;32:567–

[54] Kollara A, Brown TJ. Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity. Cell Mol Life Sci CMLS.

[55] Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci

[56] Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. J Invest Dermatol.

[57] Yang Y-C, Fu H-C, Wu C-Y, Wei K-T, Huang K-E, Kang H-Y. Androgen receptor accelerates premature senescence of human dermal papilla cells in association with DNA

[58] Ito M, Kizawa K, Hamada K, Cotsarelis G. Hair follicle stem cells in the lower bulge form the secondary germ, a biochemically distinct but functionally equivalent progenitor cell population, at the termination of catagen. Differentiation. 2004;72:548–557.

Transl Med. 2012;4:126ra34–126ra34. doi:10.1126/scitranslmed.3003122

damage. PLoS One. 2013;8:e79434. doi:10.1371/journal.pone.0079434


[85] Suzuki H, Yabuta N, Okada N, Torigata K, Aylon Y, Oren M, et al. Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis. J Cell Sci. 2013;126:4358–68. doi:10.1242/jcs.125815

[72] Kandyba E, Hazen VM, Kobielak A, Butler SJ, Kobielak K. Smad1 and 5 but not Smad8 establish stem cell quiescence which is critical to transform the premature hair follicle during morphogenesis toward the postnatal state. Stem Cells Dayt Ohio. 2014;32:534–

[73] Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Fact. 2004;22:233–

[74] Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan.

[75] Sakaki-Yumoto M, Katsuno Y, Derynck R. TGF-β family signaling in stem cells. Biochim

[76] Walsh C, Hu P, Batt J, Santos C. Microarray meta-analysis and cross-platform normalization: integrative genomics for robust biomarker discovery. Microarrays. 2015;4:389–

[77] Sivachenko AY, Yuryev A, Daraselia N, Mazo I. Molecular networks in microarray analysis. J Bioinform Comput Biol. 2007;5:429–56. doi:10.1142/S0219720007002795

[78] Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50. doi:10.1073/

[79] Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 2013;41:

[80] Chen W, Yang C-C, Tsai R-Y, Liao C-Y, Yen Y-T, Hung C-L, et al. Expression of sexdetermining genes in the scalp of men with androgenetic alopecia. Dermatology.

[81] Yamaguchi Y, Itami S, Watabe H, Yasumoto K-I, Abdel-Malek ZA, Kubo T, et al. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol.

[82] Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, et al. Ligandspecific dynamics of the androgen receptor at its response element in living cells. Mol

[83] Mao B, Zhang Z, Wang G. BTG2: a rising star of tumor suppressors (review). Int J Oncol.

[84] Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem.

47. doi:10.1002/stem.1548

170 Hair and Scalp Disorders

241. doi:10.1080/08977190412331279890

406. doi:10.3390/microarrays4030389

D991–5. doi:10.1093/nar/gks1193

2007;214:199–204. doi:10.1159/000099583

2004;165:275–85. doi:10.1083/jcb.200311122

2015;46:459–64. doi:10.3892/ijo.2014.2765

2004;279:32633–42. doi:10.1074/jbc.M400642200

Cell Biol. 2007;27:1823–43. doi:10.1128/MCB.01297-06

pnas.0506580102

Curr Biol. 2009;19:R132–42. doi:10.1016/j.cub.2008.12.005

Biophys Acta. 2013;1830:2280–96. doi:10.1016/j.bbagen.2012.08.008


[111] Auld KL, Berasi SP, Liu Y, Cain M, Zhang Y, Huard C, et al. Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling. J Mol Endocrinol. 2012;48:177–91. doi:10.1530/JME-11-0140

[98] Piscopo DM, Johansen EB, Derynck R. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. J Biol Chem. 2009;284:31690–703. doi:10.1074/jbc.

[99] Fantauzzo KA, Christiano AM. Trps1 activates a network of secreted Wnt inhibitors and transcription factors crucial to vibrissa follicle morphogenesis. Dev Camb Engl.

[100] Schlake T. Krox20, a novel candidate for the regulatory hierarchy that controls hair shaft

[101] Fang F, Shangguan AJ, Kelly K, Wei J, Gruner K, Ye B, et al. Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses.

[102] Collins S, Waickman A, Basson A, Kupfer A, Licht JD, Horton MR, et al. Regulation of CD4+ and CD8+ effector responses by Sprouty-1. PLoS One. 2012;7:e49801. doi:10.1371/

[103] Thisse B, Thisse C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol. 2005;287:390–402. doi:10.1016/j.ydbio.2005.09.011 [104] Munkley J, Lafferty NP, Kalna G, Robson CN, Leung HY, Rajan P, et al. Androgenregulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in

[105] Yueh M-F, Li T, Evans RM, Hammock B, Tukey RH. Triclocarban mediates induction of xenobiotic metabolism through activation of the constitutive androstane receptor and the estrogen receptor alpha. PLoS One. 2012;7:e37705. doi:10.1371/journal.pone.

[106] DuSell CD, Nelson ER, Wittmann BM, Fretz JA, Kazmin D, Thomas RS, et al. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators. Mol

[107] Jung S, Li C, Duan J, Lee S, Kim K, Park Y, et al. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition.

[108] Ao J, Meng J, Zhu L, Nie H, Yang C, Li J, et al. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol.

[109] Liao G, Chen L-Y, Zhang A, Godavarthy A, Xia F, Ghosh JC, et al. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J Biol Chem.

[110] O'Kane M, Markham T, McEvoy AN, Fearon U, Veale DJ, FitzGerald O, et al. Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition. J Invest Dermatol. 2008;128:300–10. doi:10.1038/sj.jid.5701023

Endocrinol Baltim Md. 2010;24:33–46. doi:10.1210/me.2009-0339

Oncotarget. 2015;6:29060–75. doi:10.18632/oncotarget.5072

2012;6:507–15. doi:10.1016/j.molonc.2012.06.005

2003;278:5052–61. doi:10.1074/jbc.M206374200

prostate cancer cells. BMC Cancer. 2015;15:9. doi:10.1186/s12885-015-1012-8

bending. Mech Dev. 2006;123:641–8. doi:10.1016/j.mod.2006.06.001

Am J Pathol. 2013;183:1197–208. doi:10.1016/j.ajpath.2013.06.016

M109.052316

172 Hair and Scalp Disorders

journal.pone.0049801

0037705

2012;139:203–14. doi:10.1242/dev.069971


**Section 5**

**Cicatricial Alopecia**

[124] Lu S, Jenster G, Epner DE. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol Endocrinol

[125] Vitolo MI, Anglin IE, Mahoney WM, Renoud KJ, Gartenhaus RB, Bachman KE, et al. The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biol Ther. 2007;6:856–63. doi:10.4161/cbt.6.6.4241

[126] Schmidt M, Asirvatham AJ, Chaudhary J. Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells. Cell Mol Biol Lett. 2010;15:272–

[127] Rendl M, Lewis L, Fuchs E. Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol. 2005;3:e331. doi:10.1371/journal.pbio.0030331

[128] Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene. 2002;21:4879–84. doi:10.1038/sj.onc.1205623 [129] Simanainen U, Ryan T, Li D, Suarez FG, Gao YR, Watson G, et al. Androgen receptor actions modify skin structure and chemical carcinogen-induced skin cancer susceptibil-

[130] Nadeau RJ, Toher JL, Yang X, Kovalenko D, Friesel R. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2. J Cell Biochem. 2007;100:151–60. doi:10.

ity in mice. Horm Cancer. 2015;6:45–53. doi:10.1007/s12672-014-0210-1

Baltim Md. 2000;14:753–60. doi:10.1210/mend.14.5.0461

95. doi:10.2478/s11658-010-0007-3

1002/jcb.21040

174 Hair and Scalp Disorders

Provisional chapter
